Aspartame

This is the claim behind most of the alarm. On July 14, 2023, IARC classified aspartame as Group 2B, "possibly carcinogenic to humans," based on limited evidence in humans and animals; that is a hazard classification, not proof that ordinary exposure levels cause cancer. In the same 2023 evaluation cycle, JECFA kept the acceptable daily intake at 0-40 mg/kg/day, concluding the human cancer evidence was not convincing enough to change risk guidance. Net: the signal is real enough to justify more research, but not strong enough to say normal intake clearly causes cancer.

For most people, phenylalanine from aspartame is handled normally. For people with phenylketonuria (PKU), it is different: phenylalanine can accumulate and cause harm, which is why aspartame-containing products carry a warning. This is not social-media scaremongering; it is a genuine, specific medical exception built into food and medicine labeling. It does not mean aspartame is uniquely dangerous for everyone else, but it does mean anyone with PKU, or caring for a child with PKU, should treat the warning seriously and check medicines as well as foods.

Headache complaints around aspartame are longstanding, and the trial record is genuinely mixed. A 1994 crossover trial found more headache-days during aspartame periods in a subset of self-identified sensitive participants, but later blinded work, including a 2015 randomized crossover study in people who believed they were sensitive, found no detectable acute symptom or metabolic effect versus control. That leaves a reasonable middle position: population-wide migraine claims are not well proven, but some individuals may still notice a personal trigger and choose to avoid it.

One of the most repeated online claims is that tasting sweetness without sugar causes a large insulin spike or meaningfully worsens glucose control. Human trials do not support that as a general rule for aspartame. Acute and short-term randomized studies usually find negligible effects on glucose and insulin compared with water, and far smaller responses than sugar-containing drinks. That does not prove every sweetener behaves identically in every setting, but for aspartame specifically the "it spikes insulin like sugar" claim is stronger on social media than in controlled human data.

When aspartame replaces sugar rather than being added on top of an already high-calorie diet, randomized trials on low-calorie sweeteners generally show lower energy intake and modestly better weight-control outcomes than sugar-sweetened versions. The key word is substitution. Evidence is much less exciting when the comparison is plain water, and aspartame is not a fat-loss ingredient by itself. Still, the trial-level picture is reasonably consistent that swapping sugar for low-calorie sweeteners can help some people reduce calories, especially through beverages.

Observational studies often find that people who drink more diet soda have higher body weight or worse metabolic health. That sounds alarming until you remember who tends to choose diet products: people already trying to manage weight, blood sugar, or existing health issues. Randomized trials, which handle that confounding better, usually show neutral or slightly favourable weight outcomes when non-nutritive sweeteners replace sugar. So the "diet soda proves aspartame makes you gain weight" claim overstates what those associations can tell us about cause and effect.

For most adults, the bigger question is what aspartame is displacing and what kind of diet it sits inside. Replacing several sugary drinks a day with diet versions can reduce sugar and calories; pairing diet drinks with an otherwise ultra-processed, low-fibre diet is a different health picture. Nutrition trials repeatedly show that single-ingredient effects are smaller than overall diet pattern, energy balance, and body weight changes. In LP terms: aspartame may matter at the margins, but it is rarely the main reason a diet is health-promoting or harmful.